Cellectar Biosciences Reports Q2 2026 Financial Results

What Happened
On August 13, 2026, Cellectar Biosciences, Inc. (CLRB) announced its quarterly results for the period ended June 30, 2026 and provided a corporate update in a press release. The press release was furnished as Exhibit 99.1 to the Form 8‑K and the cover page Interactive XBRL file was included as Exhibit 101.

Key Details

• Filing date: August 13, 2026; quarter covered: ended June 30, 2026.
• Press release titled “Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates” furnished as Exhibit 99.1.
• Inline XBRL cover page provided as Exhibit 101.
• Item 2.02 (Results of Operations and Financial Condition) was furnished in this Form 8‑K.

Why It Matters
This 8‑K communicates the company’s latest quarterly results and corporate update—information investors use to assess earnings, revenue trends, cash position and near‑term prospects. Investors should read the furnished press release (Exhibit 99.1) for the detailed financial figures and management commentary, as this Form 8‑K itself primarily notes the release of that information.